Clinical Trial: IBI112 in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Psoriasis
Study Type: INTERVENTIONAL
Official Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Randomized Withdrawal and Retreatment Phase III Clinical Trial Evaluating the Efficacy and Safety of Subcutaneous Injection of IBI112 in th
Brief Summary:
The purpose of this study is to evaluate the efficacy, safety, and tolerability of IBI112 in the treatment of participants with moderate to severe psoriasis
Read more